11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Inhibition of fructose-1,6-bisphosphatase by aminoimidazole carboxamide ribotide prevents growth of Salmonella enterica purH mutants on glycerol.

      The Journal of Biological Chemistry
      Adenosine Monophosphate, pharmacology, Amino Acid Sequence, Amino Acid Substitution, Aminoimidazole Carboxamide, analogs & derivatives, Fructose, metabolism, Fructose-Bisphosphatase, antagonists & inhibitors, genetics, Glycerol, Hypoglycemic Agents, Molecular Sequence Data, Mutation, Ribonucleotides, Salmonella enterica, drug effects, enzymology, growth & development, Sequence Homology, Amino Acid

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The enzyme fructose-1,6-bisphosphatase (FBP) is key regulatory point in gluconeogenesis. Mutants of Salmonella enterica lacking purH accumulate 5-amino-4-imidazole carboxamide ribotide (AICAR) and are unable to utilize glycerol as sole carbon and energy sources. The work described here demonstrates this lack of growth is due to inhibition of FBP by AICAR. Mutant alleles of fbp that restore growth on glycerol encode proteins resistant to inhibition by AICAR and the allosteric regulator AMP. This is the first report of biochemical characterization of substitutions causing AMP resistance in a bacterial FBP. Inhibition of FBP activity by AICAR occurs at physiologically relevant concentrations and may represent a form of regulation of gluconeogenic flux in Salmonella enterica.

          Related collections

          Author and article information

          Comments

          Comment on this article